TCAR-T

Xiangyun Niu1,2, Pengchao Zhang1,2, Zhongming Liu1

  • 1Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

PubMed
概括

伦丁南 (LTN) 通过增强免疫细胞功能和持久性来增强固体瘤的CAR-T细胞疗法. 这种新的策略改善了瘤控制,并可能克服癌症治疗当前的局限性.